ÂÜÀòÂÒÂ×

Ori is the Co-Founder of Biond. He serves as the company’s CFO and a member of its Board of Directors since inception. Prior to launching Biond, Ori was Co-Founder, CFO & Deputy CEO and Director at RedHill Biopharma (NASDAQ: RDHL), a late stage drug development company. During his time at RedHill he led the company’s IPO in the Tel-Aviv Stock Exchange and its dual listing on NASDAQ including several private and public financing rounds totaling over $100 million as well as overseeing two phase 3 and three phase 2 trials. Prior to RedHill, Ori was partner in ProSeed Capital Holding CVA, a Belgium-based boutique investment firm, responsible for investments and banking activities in Israel. Ori has over 20 year of experience in investment banking and consultancy for the pharma/biotech field and as a Co-Founder of pharma/biotech companies.